Home > Insider Trading > Filing (0001209191-16-133852)

Filing Details

Accession Number:: 0001209191-16-133852
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-07-25 17:09:11
Reporting Period:: 2016-07-25

Filing Date:: 2016-07-25
Accepted Time:: 2016-07-25 17:09:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1628738	Audentes Therapeutics Inc.	BOLD	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1619294	Thomas Woiwode	One Sansome Street, Suite 3630 San Francisco CA 94104		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-07-25	1,081,477	$0.00	1,081,477	No	4	C	Indirect	By Versant Venture Capital IV, L.P.
Common Stock	Acquisiton	2016-07-25	480,856	$0.00	1,562,333	No	4	C	Indirect	By Versant Venture Capital IV, L.P.
Common Stock	Acquisiton	2016-07-25	198,410	$0.00	1,760,743	No	4	C	Indirect	By Versant Venture Capital IV, L.P.
Common Stock	Acquisiton	2016-07-25	6,811	$0.00	6,811	No	4	C	Indirect	By Versant Side Fund IV, L.P.
Common Stock	Acquisiton	2016-07-25	3,029	$0.00	9,840	No	4	C	Indirect	By Versant Side Fund IV, L.P.
Common Stock	Acquisiton	2016-07-25	1,249	$0.00	11,089	No	4	C	Indirect	By Versant Side Fund IV, L.P.
Common Stock	Acquisiton	2016-07-25	34,781	$15.00	1,795,524	No	4	P	Indirect	By Versant Venture Capital IV, L.P.
Common Stock	Acquisiton	2016-07-25	219	$15.00	11,308	No	4	P	Indirect	By Versant Side Fund IV, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Versant Venture Capital IV, L.P.
No	4	C	Indirect	By Versant Venture Capital IV, L.P.
No	4	C	Indirect	By Versant Venture Capital IV, L.P.
No	4	C	Indirect	By Versant Side Fund IV, L.P.
No	4	C	Indirect	By Versant Side Fund IV, L.P.
No	4	C	Indirect	By Versant Side Fund IV, L.P.
No	4	P	Indirect	By Versant Venture Capital IV, L.P.
No	4	P	Indirect	By Versant Side Fund IV, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2016-07-25	1,081,477	$0.00	1,081,477	$0.00
Common Stock	Series B Preferred Stock	Disposition	2016-07-25	480,856	$0.00	480,856	$0.00
Common Stock	Series C Preferred Stock	Disposition	2016-07-25	198,410	$0.00	198,410	$0.00
Common Stock	Series A Preferred Stock	Disposition	2016-07-25	6,811	$0.00	6,811	$0.00
Common Stock	Series B Preferred Stock	Disposition	2016-07-25	3,029	$0.00	3,029	$0.00
Common Stock	Series C Preferred Stock	Disposition	2016-07-25	1,249	$0.00	1,249	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of the issuer's Series A Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-208842) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.
These securities are held of record by Versant Venture Capital IV, L.P. ("VVC IV"). Versant Ventures IV, LLC ("VV IV") is the sole general partner of VVC IV. The reporting person, together with each of Brian Atwood, Bradley Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk Nielsen, Robin Praeger, Rebecca Robertson and Charles Warden, are directors or members of VV IV and may be deemed to share voting and dispositive power over the securities held by VVC IV and as a result may be deemed to have beneficial ownership over such securities. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Each share of the issuer's Series B Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.
Each share of the issuer's Series C Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.
These securities are held of record by Versant Side Fund IV, L.P. ("VSF IV"). VV IV is the sole general partner of VSF IV. The reporting person, together with each of Brian Atwood, Bradley Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk Nielsen, Robin Praeger, Rebecca Robertson and Charles Warden, are directors or members of VV IV and may be deemed to share voting and dispositive power over the securities held by VSF IV and as a result may be deemed to have beneficial ownership over such securities. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.